Shah Shares Immunotherapy, STAT3 Inhibitor Data in GI Cancers

Two clinical trials presented at the 2018 ASCO Annual Meeting addressed unmet needs for select with patients with gastrointestinal (GI) cancers; however, a number of challenges remain, explained Manish A. Shah, MD.

https://www.onclive.com/web-exclusives/shah-shares-immunotherapy-stat3-inhibitor-data-in-gi-cancers

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *